Viewing Study NCT05935332


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-01-01 @ 5:44 PM
Study NCT ID: NCT05935332
Status: TERMINATED
Last Update Posted: 2024-07-22
First Post: 2023-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Sponsor: RAPT Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module